Australia markets closed

RxSight, Inc. (RXST)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
60.17+1.07 (+1.81%)
At close: 04:00PM EDT
60.09 -0.08 (-0.13%)
After hours: 07:45PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-44,496
-48,608
-66,756
-48,688
27,575
Depreciation & amortisation
4,384
4,243
4,022
3,988
4,012
Stock-based compensation
17,147
15,746
11,397
7,575
4,185
Change in working capital
-5,983
-9,072
-7,412
-2,678
-7,848
Accounts receivable
-8,882
-9,325
-6,094
-1,996
-2,076
Inventory
-898
-2,749
-7,555
-2,111
-1,307
Accounts payable
1,263
1,250
635
555
-954
Other working capital
-39,172
-46,407
-61,243
-46,648
-37,742
Other non-cash items
-
287
552
493
85
Net cash provided by operating activities
-33,138
-41,593
-58,850
-44,708
-35,203
Cash flows from investing activities
Investments in property, plant and equipment
-6,034
-4,814
-2,393
-1,940
-2,539
Purchases of investments
-212,456
-272,315
-212,657
-159,967
-97,873
Sales/maturities of investments
269,000
255,000
255,000
80,000
116,000
Net cash used for investing activities
50,510
-22,129
39,950
-81,907
15,591
Cash flows from financing activities
Debt repayment
-60,139
-60,153
-121
-27
-142
Common stock issued
50,197
105,957
7,828
121,136
0
Other financing activities
-5,847
-4,280
-1,375
443
-636
Net cash used provided by (used for) financing activities
4,211
61,524
6,332
137,342
25,237
Net change in cash
21,584
-2,192
-12,577
10,717
5,625
Cash at beginning of period
11,773
12,595
25,172
14,455
8,830
Cash at end of period
33,356
10,403
12,595
25,172
14,455
Free cash flow
Operating cash flow
-33,138
-41,593
-58,850
-44,708
-35,203
Capital expenditure
-6,034
-4,814
-2,393
-1,940
-2,539
Free cash flow
-39,172
-46,407
-61,243
-46,648
-37,742